1-2 of 2
Rama Modali
Close
Save search
Sort by
Journal Articles

FCGR3A and FCGR2A polymorphisms may not correlate with response to alemtuzumab in chronic lymphocytic leukemia

Free
Clinical Trials & Observations
Thomas S. Lin, Ian W. Flinn, Rama Modali, Teresa A. Lehman, Jennifer Webb, Sharon Waymer, Mollie E. Moran, Margaret S. Lucas, Sherif S. Farag, John C. Byrd
Journal: Blood
Blood (2005) 105 (1): 289–291.
https://doi.org/10.1182/blood-2004-02-0651
Published: 2005
Journal Articles

FcγRIIIa and FcγRIIa polymorphisms do not predict response to rituximab in B-cell chronic lymphocytic leukemia

Free
Sherif S. Farag, Ian W. Flinn, Rama Modali, Teresa A. Lehman, Donn Young, John C. Byrd
Journal: Blood
Blood (2004) 103 (4): 1472–1474.
https://doi.org/10.1182/blood-2003-07-2548
Published: 2004